Cargando…
Sodium butyrate promotes apoptosis in breast cancer cells through reactive oxygen species (ROS) formation and mitochondrial impairment
BACKGROUND: Sodium butyrate (NaBu) is a short-chain fatty acid which serves as a histon deacetylase inhibitor and has received considerable interest as a possible regulator of cancer cell death. The regulatory effect of NaBu on cancer cell growth or death has yet to be illustrated in many cancers in...
Autores principales: | Salimi, Vahid, Shahsavari, Zahra, Safizadeh, Banafsheh, Hosseini, Ameinh, Khademian, Narges, Tavakoli-Yaraki, Masoumeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669027/ https://www.ncbi.nlm.nih.gov/pubmed/29096636 http://dx.doi.org/10.1186/s12944-017-0593-4 |
Ejemplares similares
-
Evaluation of local and circulating osteopontin in malignant and benign primary bone tumors
por: Nazarizadeh, Ali, et al.
Publicado: (2021) -
The local and circulating SOX9 as a potential biomarker for the diagnosis of primary bone cancer
por: Hosseini, Ameinh, et al.
Publicado: (2020) -
The clinical significance of CD44v6 in malignant and benign primary bone tumors
por: Hosseini, Ameinh, et al.
Publicado: (2023) -
Expression pattern and clinical significance of β-catenin gene and protein in patients with primary malignant and benign bone tumors
por: Khademian, Narges, et al.
Publicado: (2022) -
Evaluation of the expression pattern and diagnostic value of PPARγ in malignant and benign primary bone tumors
por: Eghtedari, Amir Reza, et al.
Publicado: (2022)